Roberts Richard John Insider Trades

Insider Trading History

Track insider trading activity for Roberts Richard John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $1.35k 4,200 shares
Last Trade
Nov 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5k 4,200 shares
$2.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $4.81k 15,000 shares
Last Trade
Mar 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$413k 15,000 shares
$27.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $4.01k 12,500 shares
Last Trade
Jan 19, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$161M 12,500 shares
$12,888.75
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $69.6k 216,887 shares
Last Trade
Apr 13, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.06B 30,984 shares
$66,562.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $0 0 shares
Last Trade
Apr 13, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.06B 30,984 shares
$66,562.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $0 0 shares
Last Trade
Feb 16, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.85B 58,403 shares
$82,968.75
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $59.6k 185,903 shares
Last Trade
Feb 16, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.85B 58,403 shares
$82,968.75
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $4.01k 12,500 shares
Last Trade
Jan 18, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02B 12,500 shares
$81,562.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $40.9k 127,500 shares
Last Trade
Aug 19, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.82B 70,000 shares
$140,250.00
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $18.7k 58,403 shares
Last Trade
Aug 19, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.82B 70,000 shares
$140,250.00
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $20.8k 65,000 shares
Last Trade
Feb 10, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.4B 35,000 shares
$68,625.00
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $41.2k 128,403 shares
Last Trade
Feb 10, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.4B 35,000 shares
$68,625.00
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $9.62k 30,000 shares
Last Trade
Dec 29, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72B 20,000 shares
$135,937.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $52.4k 163,403 shares
Last Trade
Dec 29, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72B 20,000 shares
$135,937.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $4.01k 12,500 shares
Last Trade
Dec 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.73B 12,500 shares
$138,187.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $4.01k 12,500 shares
Last Trade
Jul 31, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.41B 12,500 shares
$272,812.50
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $16k 50,000 shares
Last Trade
Dec 10, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.07B 50,000 shares
$21,375.00
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $3.21k 10,000 shares
Last Trade
Aug 08, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$214M 10,000 shares
$21,375.00
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $235k 733,612 shares
Last Trade
Aug 08, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$214M 10,000 shares
$21,375.00
$0.32
InVivo Therapeutics Holdings
InVivo Therapeutics Holdings NVIV
Director
Holding Value $16k 50,000 shares
Last Trade
Dec 10, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67B 50,000 shares
$33,375.00
$0.32

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up